Literature DB >> 25260303

[Deep skin infection with Scedosporium apiospermum-infection in a renal transplant patient].

T Strunk1, J-H Blume, R-M Szeimies.   

Abstract

A 57-year-old immunosuppressed patient presented with multiple erythematous papules and pustules as well as isolated ulcerations on the right lower leg and subcutaneous nodules on the right thigh. The biopsy revealed granulomatous inflammation with numerous fungal hyphae, which were IDentified as Scedosporium apiospermum by PCR. He was treated with voriconazole 2 × 200 mg daily as well assurgical debridement. Scedosporium apiospermum is a rare pathogenic agent of deep mold fungus infections. Skin infections with Scedosporium apiospermum are underdiagnosed because of different clinical manifestations. In immunosuppressed patients, an infection represents a potentially life-threatening complication. Precise identification of the agent with introduction of antimycotic therapy appears to be pivotal to prevent fulminant disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25260303     DOI: 10.1007/s00105-014-3518-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection.

Authors:  Mariola Moreno Azofra; José Luis Peña Somovilla; Miguel Carrascosa Porras; Laura Hurtado Carrillo; Rafael Daroca Pérez
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

2.  Successful topical therapy with voriconazole: pseudallescheriasis after injury.

Authors:  Ina Tammer; Michael Seibold; Hardy Krause; Kathrin Tintelnot; Wolfgang König; Brigitte König
Journal:  J Trauma       Date:  2007-05

3.  Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.

Authors:  Shahid Husain; Patricia Muñoz; Graeme Forrest; Barbara D Alexander; Jyoti Somani; Kathleen Brennan; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

4.  Deep skin infection of Scedosporium apiospermum in a patient with refractory idiopathic thrombocytopenic purpura.

Authors:  Makoto Takeuchi; Chikamasa Yoshida; Yusuke Ota; Yutaka Fujiwara
Journal:  Intern Med       Date:  2011-06-15       Impact factor: 1.271

5.  Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.

Authors:  Fiona O Zwald; Margaret Spratt; Bianca D Lemos; Emir Veledar; Clint Lawrence; George Marshall Lyon; Suephy C Chen
Journal:  Dermatol Surg       Date:  2012-05-02       Impact factor: 3.398

Review 6.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.

Authors:  C H Heath; M A Slavin; T C Sorrell; R Handke; A Harun; M Phillips; Q Nguyen; L Delhaes; D Ellis; W Meyer; S C A Chen
Journal:  Clin Microbiol Infect       Date:  2009-06-22       Impact factor: 8.067

  7 in total
  1 in total

1.  The Synergistic Effect of Tacrolimus (FK506) or Everolimus and Azoles Against Scedosporium and Lomentospora Species In Vivo and In Vitro.

Authors:  Zikuo Wang; Mei Liu; Luyao Liu; Linyun Li; Lihua Tan; Yi Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-04-14       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.